Thus, gemcitabine strongly inhibits the formation of tumor clusters and proliferation of cells from cultured lung metastasis, perhaps via the elimination of HDAC1-dependent CAFs (Figure 9D), which have a high rate of proliferation. Here, HDAC1 is linked to neoplasm.